Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05155501 · ClinicalTrials.gov registry record · NA
Clinical Trial of Approaches to Prostate Cancer Surgery
A NA study of Prostate Cancer, sponsored by Weill Medical College of Cornell University.
- Recruiting
- Registry status
- NA
- Development phase
- 600
- Enrollment target
- 5
- Study locations
NCT05155501: Recruiting NA study of Prostate Cancer, sponsored by Weill Medical College of Cornell University.
NCT05155501 is a NA study of Prostate Cancer that is actively recruiting participants, run by Weill Medical College of Cornell University. The registered enrollment target is 600 participants, roughly in line with the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target. The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05155501, a NA study of Prostate Cancer, is actively recruiting participants, sponsored by Weill Medical College of Cornell University.
- RECRUITING
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
- 5
- Study locations
Study Summary
This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have similar cancer control (primary outcome) and sexual function outcomes; and significantly better urinary function, penile shortening/deformity and inguinal hernia risks as compared to radical prostatectomy.
Primary Outcome
Presence of cancer cells at the prostate margin is standardized as a positive surgical margin through professional guideline consensus.
Conditions Studied
Interventions
- PROCEDURE Robot-assisted radical prostatectomy (RP)
- PROCEDURE Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP)
Study Locations (5)
New York
- NewYork-Presbyterian Queens - Flushing
- Weill Cornell Medicine - New York
District of Columbia
- Georgetown University - Washington D.C.
Illinois
- Northwestern University - Chicago
Maryland
- Johns Hopkins University - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2023-05-15 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05155501 shows while recruiting
NCT05155501 is an interventional study that assigns participants to a tested intervention. The registered 600 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 607-participant average among 735 other Prostate Cancer trials with a reported enrollment target.
The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 2 interventions - of which Robot-assisted radical prostatectomy (RP) is the first listed.
NCT05155501 lists 5 locations in 4 states (New York, District of Columbia, Illinois).
Frequently Asked Questions
What is clinical trial NCT05155501 about?
NCT05155501 is a clinical study titled "Clinical Trial of Approaches to Prostate Cancer Surgery". This is a prospective, randomized controlled trial to compare cancer control and health-related quality of life following pelvic fascia-sparing radical prostatectomy versus standard radical prostatectomy. The investigators hypothesize that pelvic fascia-sparing radical prostatectomy will have simil...
What is the current status of trial NCT05155501?
This trial is currently recruiting. It is a NA study. The enrollment target is 600 participants. The study started on 2023-05-15. Estimated completion is 2026-12.
What conditions does trial NCT05155501 study?
This clinical trial studies the following conditions: Prostate Cancer.
What interventions are being tested in trial NCT05155501?
The interventions under investigation include: Robot-assisted radical prostatectomy (RP) (PROCEDURE), Pelvic fascia-sparing robot-assisted radical prostatectomy (PFS-RP) (PROCEDURE).
Who is sponsoring clinical trial NCT05155501?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05155501 being conducted?
This trial has 5 study locations across District of Columbia, Illinois, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05155501's enrollment target sits among peer trials
600 96th of 735 higher than 639 of 735 other Prostate Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Prostate Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Health Literacy in African-American Prostate Cancer Patients
RECRUITING · NA
-
Pilot Study to Investigate Magnetic Resonance (MR) Image Guided Focal Therapy in Prostate Cancer
RECRUITING · NA
-
Diffusion Basis Spectrum Imaging of the Prostate
RECRUITING · NA
-
Micro-UltraSound In Cancer - Active Surveillance
RECRUITING · NA
-
Precise Oncology Interventions in Nutrition and Training (OnPoint)
RECRUITING · NA
-
SBRT Boost for Unfavorable Prostate Cancer'
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
- NCT01866371 · 600 participants
High Resolution Retinal Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI